The results of the current study represent that the most important polymorphisms in HCC patients in comparison with CHB patients were ATG16L1 rs2241880 and rs77859116, rs510432, and rs548234 in ATG5. The gene discussed is ATG16L1; the disease is hepatocellular carcinoma.